drugset / Trial / NCT00987272
Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of the study is to demonstrate safety and efficacy of Olopatadine 0.2% compared to its vehicle in Japanese subjects in the treatment of acute allergen-mediated conjunctivitis using the conjunctival allergen challenge (CAC) test.
Timeline
- Start
- 2009-10
- Primary completion
- 2009-11
- Completion
- 2009-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olopatadine | Other / unclassified | 0.1 % | Other |
| Subject | Olopatadine | Other / unclassified | 0.2 % | Other |